IQVIA Holdings EBITDA 2011-2024 | IQV
IQVIA Holdings annual and quarterly EBITDA history from 2011 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- IQVIA Holdings EBITDA for the quarter ending March 31, 2024 was $0.775B, a 6.46% increase year-over-year.
- IQVIA Holdings EBITDA for the twelve months ending March 31, 2024 was $3.167B, a 8.53% increase year-over-year.
- IQVIA Holdings 2023 annual EBITDA was $3.12B, a 5.98% increase from 2022.
- IQVIA Holdings 2022 annual EBITDA was $2.944B, a 10.1% increase from 2021.
- IQVIA Holdings 2021 annual EBITDA was $2.674B, a 31.34% increase from 2020.
| IQVIA Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $3,120 |
| 2022 | $2,944 |
| 2021 | $2,674 |
| 2020 | $2,036 |
| 2019 | $1,992 |
| 2018 | $1,893 |
| 2017 | $1,728 |
| 2016 | $926 |
| 2015 | $793 |
| 2014 | $718 |
| 2013 | $592 |
| 2012 | $504 |
| 2011 | $467 |
| 2010 | $498 |
| IQVIA Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $775 |
| 2023-12-31 | $822 |
| 2023-09-30 | $783 |
| 2023-06-30 | $787 |
| 2023-03-31 | $728 |
| 2022-12-31 | $740 |
| 2022-09-30 | $724 |
| 2022-06-30 | $726 |
| 2022-03-31 | $754 |
| 2021-12-31 | $728 |
| 2021-09-30 | $642 |
| 2021-06-30 | $634 |
| 2021-03-31 | $670 |
| 2020-12-31 | $638 |
| 2020-09-30 | $511 |
| 2020-06-30 | $375 |
| 2020-03-31 | $512 |
| 2019-12-31 | $483 |
| 2019-09-30 | $507 |
| 2019-06-30 | $494 |
| 2019-03-31 | $508 |
| 2018-12-31 | $504 |
| 2018-09-30 | $467 |
| 2018-06-30 | $454 |
| 2018-03-31 | $468 |
| 2017-12-31 | $423 |
| 2017-09-30 | $453 |
| 2017-06-30 | $413 |
| 2017-03-31 | $439 |
| 2016-12-31 | $295 |
| 2016-09-30 | $232 |
| 2016-06-30 | $183 |
| 2016-03-31 | $216 |
| 2015-12-31 | $219 |
| 2015-09-30 | $205 |
| 2015-06-30 | $194 |
| 2015-03-31 | $175 |
| 2014-12-31 | $193 |
| 2014-09-30 | $181 |
| 2014-06-30 | $172 |
| 2014-03-31 | $172 |
| 2013-12-31 | $162 |
| 2013-09-30 | $154 |
| 2013-06-30 | $132 |
| 2013-03-31 | $143 |
| 2012-12-31 | $124 |
| 2012-09-30 | $137 |
| 2012-06-30 | $127 |
| 2012-03-31 | $117 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.346B | $14.984B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.930B | 27.22 |
| Intuitive Surgical (ISRG) | United States | $155.197B | 87.88 |
| Alcon (ALC) | Switzerland | $45.300B | 32.45 |
| DexCom (DXCM) | United States | $42.890B | 61.63 |
| IDEXX Laboratories (IDXX) | United States | $38.872B | 45.56 |
| Edwards Lifesciences (EW) | United States | $35.975B | 23.05 |
| STERIS (STE) | Ireland | $22.495B | 26.28 |
| Waters (WAT) | United States | $18.406B | 27.05 |
| Hologic (HOLX) | United States | $18.175B | 20.33 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.783B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.965B | 13.97 |
| Teleflex (TFX) | United States | $10.480B | 16.31 |
| Sysmex ADR (SSMXY) | Japan | $9.774B | 30.65 |
| Globus Medical (GMED) | United States | $9.713B | 28.47 |
| Penumbra (PEN) | United States | $7.369B | 83.74 |
| Glaukos (GKOS) | United States | $5.926B | 0.00 |
| Masimo (MASI) | United States | $5.838B | 33.57 |
| TransMedics (TMDX) | United States | $4.809B | 456.22 |
| Integer Holdings (ITGR) | United States | $3.876B | 22.68 |
| PROCEPT BioRobotics (PRCT) | United States | $3.312B | 0.00 |
| Inari Medical (NARI) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.894B | 17.19 |
| Tandem Diabetes Care (TNDM) | United States | $2.626B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.485B | 10.84 |
| Veracyte (VCYT) | United States | $1.816B | 0.00 |
| RxSight (RXST) | United States | $1.676B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.521B | 0.00 |
| Artivion (AORT) | United States | $1.145B | 109.84 |
| Pulse Biosciences (PLSE) | United States | $1.084B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.065B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.052B | 20.46 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.783B | 0.00 |
| Paragon 28 (FNA) | United States | $0.718B | 0.00 |
| SiBone (SIBN) | United States | $0.658B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.620B | 0.00 |
| IRadimed (IRMD) | United States | $0.598B | 33.51 |
| Mesa Laboratories (MLAB) | United States | $0.585B | 17.31 |
| Pacific Biosciences Of California (PACB) | United States | $0.519B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| AxoGen (AXGN) | United States | $0.408B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.400B | 0.00 |
| Nevro (NVRO) | United States | $0.363B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.307B | 10.50 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.242B | 0.00 |
| NeuroPace (NPCE) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.229B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.227B | 11.52 |
| ClearPoint Neuro (CLPT) | United States | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.174B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.147B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 21.86 |
| Spectral Diagnostics (EDTXF) | Canada | $0.103B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.061B | 0.00 |
| Neuronetics (STIM) | United States | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.035B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.022B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.021B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |